Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)

NCT06922994 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Arrhythmogenic Cardiomyopathy

Interventions

DRUG: Atorvastatin 80 mg/day
DRUG: Placebo atorvastatin

Sponsor

Centro Cardiologico Monzino

Collaborators

[object Object]
[object Object]
[object Object]